These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 18064718)

  • 1. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
    Chen P; Tian J; Kovesdi I; Bruder JT
    J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated administration of adenovector in the eye results in efficient gene delivery.
    Hamilton MM; Brough DE; McVey D; Bruder JT; King CR; Wei LL
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):299-305. PubMed ID: 16384977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
    Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
    Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
    Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
    Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice.
    Bouchard S; MacKenzie TC; Radu AP; Hayashi S; Peranteau WH; Chirmule N; Flake AW
    J Gene Med; 2003 Nov; 5(11):941-50. PubMed ID: 14601131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced transgene expression in the mouse skeletal muscle infected by the adeno-associated viral vector with the human elongation factor 1alpha promoter and a human chromatin insulator.
    Mori-Uchino M; Takeuchi T; Murakami I; Yano T; Yasugi T; Taketani Y; Nakagawa K; Kanda T
    J Gene Med; 2009 Jul; 11(7):598-604. PubMed ID: 19399759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of promoter strength in mouse and rat primary hepatocytes using adenovirus vectors.
    Arita E; Kondoh M; Isoda K; Nishimori H; Yoshida T; Mizuguchi H; Yagi K
    Eur J Pharm Biopharm; 2008 Sep; 70(1):1-6. PubMed ID: 18468873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses against tetracycline-dependent transactivators affect long-term expression of mouse erythropoietin delivered by a helper-dependent adenoviral vector.
    Lena AM; Giannetti P; Sporeno E; Ciliberto G; Savino R
    J Gene Med; 2005 Aug; 7(8):1086-96. PubMed ID: 15772935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle stem cells can act as antigen-presenting cells: implication for gene therapy.
    Cao B; Bruder J; Kovesdi I; Huard J
    Gene Ther; 2004 Sep; 11(17):1321-30. PubMed ID: 15175641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective repeat administration with adenovirus vectors to the muscle.
    Chen P; Kovesdi I; Bruder JT
    Gene Ther; 2000 Apr; 7(7):587-95. PubMed ID: 10819574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo.
    Rivera AA; Wang M; Suzuki K; Uil TG; Krasnykh V; Curiel DT; Nettelbeck DM
    Virology; 2004 Mar; 320(1):121-34. PubMed ID: 15003868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo.
    Fleury S; Simeoni E; Zuppinger C; Déglon N; von Segesser LK; Kappenberger L; Vassalli G
    Circulation; 2003 May; 107(18):2375-82. PubMed ID: 12695294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential influence of the E4 adenoviral genes on viral and cellular promoters.
    Grave L; Dreyer D; Dieterle A; Leroy P; Michou AI; Doderer C; Pavirani A; Lusky M; Mehtali M
    J Gene Med; 2000; 2(6):433-43. PubMed ID: 11199264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.
    Sung RS; Qin L; Bromberg JS
    Mol Ther; 2001 May; 3(5 Pt 1):757-67. PubMed ID: 11356080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
    Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
    J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained expression of human apo A-I following adenoviral gene transfer in mice.
    De Geest B; Van Linthout S; Collen D
    Gene Ther; 2001 Jan; 8(2):121-7. PubMed ID: 11313781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
    Van Linthout S; Lusky M; Collen D; De Geest B
    Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral-mediated skeletal muscle transcriptional targeting using chimeric tissue-specific promoters.
    Frauli M; Ribault S; Neuville P; Augé F; Calenda V
    Med Sci Monit; 2003 Feb; 9(2):BR78-84. PubMed ID: 12601283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.